Bionime (TPE:4737) GF Score: 63/100 (As of Jul. 09, 2026) — Near Median


TPE:4737 Bionime Corp TPE:4737
63 GF Score
Price NT$57.90
GF Value NT$58.83
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Bionime GF Score?

Bionime TPE:4737 +1.58% 63 GF Score is 63 as of Jul. 09, 2026, which is 5% below its 10-year median of 66.00. GuruFocus rates TPE:4737 with a GF Score™ of 63/100 and a GF Value™ of NT$58.83 (Fairly Valued). The stock has 7 warning signs investors should review.

Bionime has the GF Score of 63, which implies that the company might have Poor future performance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 1/10
2. Profitability Rank : 5/10
3. Growth Rank : 5/10
4. GF Value Rank : 9/10
5. Momentum Rank : 5/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Bionime might have Poor future performance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Bionime  (TPE:4737) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score Performance Potential and All-in-One Screener Examples (1)
91 - 100Highest outperformance potential
81 - 90Good outperformance potential
71 - 80Likely to have average performance
51 - 70Poor future performance potential
0 - 50Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Bionime GF Score Related Terms

TPE:4737 vs ISRG, BDX, MDLN: GF Score Comparison

For the Medical Instruments & Supplies subindustry, Bionime's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bionime GF Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bionime's GF Score distribution charts can be found below:

* The bar in red indicates where Bionime's GF Score falls into.


TPE:4737
63GF Score
Bionime Corp TPE:4737
GF Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Score →
What does a GF Score of 63 mean?
Bionime (TPE:4737) has a GF Score of 63 as of Jul. 09, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bionime and its competitors. This is near median its historical median of 66.00. Over the past decade, Bionime's GF Score has ranged from 27.00 to 78.00.
Is Bionime's GF Score too high?
Bionime's current GF Score of 63 is near median its 10-year median of 66.00. Over the past 10 years, this metric has ranged from a low of 27.00 to a high of 78.00. Overall, Bionime has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bionime's GF Score compare to ISRG and BDX?
Bionime's GF Score of 63 can be compared against companies in the Medical Devices & Instruments industry. Historically, Bionime's own GF Score has ranged from 27.00 to 78.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Bionime and its competitors. Bionime's current GF Score is 63, which is near median its own 10-year median of 66.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bionime stock overvalued right now?
Based on GuruFocus' analysis, Bionime (TPE:4737) is currently considered Fairly Valued. The stock's GF Value™ is NT$58.83, compared to a current price of NT$57.90 — trading 1.6% below its estimated fair value. The current GF Score is 63, which is near median its 10-year median of 66.00. Bionime's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Bionime (TPE:4737), the current GF Score is 63 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bionime (TPE:4737) Overvalued in 2026?

Based on GuruFocus' analysis, Bionime stock appears to be undervalued. The current stock price of NT$57.90 is trading 1.6% below its estimated GF Value™ of NT$58.83. GuruFocus considers Bionime to be Fairly Valued.

Key valuation signals for TPE:4737:

  • GF Score: 63 (near median its 10-year median of 66.00)
  • GF Value™: NT$58.83 vs. price of NT$57.90 (1.6% below fair value)
  • GF Score™: 63/100 with 7 warning signs

No single metric tells the full story. See the TPE:4737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bionime Business Description

Address No. 100, Daqing Street, Section 2, South District, Taichung, TWN, 40242
Bionime Corp is engaged in the manufacturing and selling of medical instruments, providing biotechnology services, examining pharmaceuticals, and selling precision instruments. The company's revenue is derived from the sale of blood glucose meters and test strips to domestic and foreign clients. Geographically, it operates in Algeria, China, Switzerland, the United States, Belarus, Egypt, the United Arab Emirates, and other countries, of which it derives the maximum revenue from Algeria.
63GF Score

Get the complete analysis for TPE:4737

GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$57.90
Price
NT$58.83
GF Value